Making Medicines Affordable: A National Imperative
In an era where healthcare costs continue to soar, the affordability of medicines has become a pressing national concern. The […]
Making Medicines Affordable: A National Imperative Read Post »
Unapproved Drugs: Opportunities for Rapid Approval and Market Exclusivity
Unapproved drugs present a unique opportunity for companies seeking rapid approval and market exclusivity. This article delves into the intricacies
Unapproved Drugs: Opportunities for Rapid Approval and Market Exclusivity Read Post »
Strategies for Pharmaceutical Companies to Boost Their Exports
Pharmaceutical companies are constantly seeking ways to expand their reach and increase their exports. The pharmaceutical industry plays a crucial
Strategies for Pharmaceutical Companies to Boost Their Exports Read Post »
Patent Protection Strategies: Safeguarding Your Innovations in a Competitive World
Protecting your intellectual property is more crucial than ever. Patent protection strategies are essential tools for inventors, entrepreneurs, and companies
Patent Protection Strategies: Safeguarding Your Innovations in a Competitive World Read Post »
Factors that influence the development of generic drugs in the US
Generic drugs play a crucial role in providing affordable healthcare options to millions of Americans. The development of these cost-effective
Factors that influence the development of generic drugs in the US Read Post »
Balancing Patents and Drug Prices: Navigating the Complex Landscape of Pharmaceutical Innovation and Accessibility
The delicate balance between patent protection and drug affordability has become a critical issue. As we delve into this complex
Re-Thinking Management Strategies for Specialty Drug Cost Containment
In the ever-evolving landscape of healthcare, specialty drugs have emerged as both a blessing and a challenge. While these innovative
Re-Thinking Management Strategies for Specialty Drug Cost Containment Read Post »
Leveraging affordable innovation to tackle India’s healthcare challenge
India, a country of 1.4 billion people, faces significant healthcare challenges. With a rapidly growing population and a diverse landscape
Leveraging affordable innovation to tackle India’s healthcare challenge Read Post »
A Comparison of Generic Drug Prices in Seven European Countries: A Methodological Analysis
This paper was originally published by Olivier J. Wouters and Panos G. Kanavos in BMC Health Services Research 2017 17:242 https://doi.org/10.1186/s12913-017-2184-5 © The Author(s). 2017 Abstract Background Policymakers and researchers
